Year: 2022-23

Company: Amgen Inc. (Spring Only)

Liaison(s): Seyed Mohammad Amoozegar, Kevin Baliat, Isela Marin, Austin Shardo, Ceylan Undey

The Global Study Planners (GSPs) ensure that clinical final drug product (FDP) supply is consistently available for 20,000+ patients across 200+ clinical studies globally. Although there are several digital tools in place to support planning activities, there may be room for more automation. To kick start automation efforts, the Digital MCS team needs to understand the problems that planners face that are a result of manual efforts, identify areas of process improvement through digital means, & the business value of digital efforts. KGI Team will need to identify opportunities for automation across the GSP workflows & business processes & develop business cases & priorities for each automation candidate.